Organization | Hospital Clinic of Barcelona

Hospital Clinic of Barcelona Report issue

Academic/Hospital Phase 1 Phase 4

Organization Overview

First Clinical Trial

2012

NCT01529749

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2016

Timeline

NOW

Now

Alternative names

Anna Baiges | Felipe Garcia

Active Ingredients

Drugs in Phase 4 Trials (7)

albumin (Human) (Plasbumin) (1 trial)

efavirenz (sustiva) (1 trial)

emtricitabine (emtriva) (1 trial)

losartan (cozaar) (1 trial)

raltegravir (isentress) (1 trial)

tenofovir (viread) (1 trial)

terlipressin (Terlivaz) (1 trial)

Drugs in Phase 1 Trials (1)

allogeneic adipose derived mesenchymal stem cell (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Acute-On-Chronic Liver Failure (Phase 1)

End Stage Liver Disease (Phase 1)

Hepatic Insufficiency (Phase 1)

Hepatorenal Syndrome (Phase 4)

Inflammation (Phase 4)

Liver Failure (Phase 1)

Syndrome (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 3
# of Trial APIs: 8